Wei Wang
Impact in
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 0.5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 60
- Circular RNAs in diseases 49
- Epigenetics and DNA Methylation 38
- RNA Research and Splicing 28
- Cancer-related gene regulation 24
- Cancer Research 160
- Cancer-related molecular mechanisms research 106
- MicroRNA in disease regulation 61
- Co-authors
- Jianxin Qiu (2 shared papers)Zuowei Li (2 shared papers)Yigang Zeng (2 shared papers)Ming Luo (2 shared papers)Zhihong Liu (2 shared papers)Robert Shoemaker (3 shared papers)Kun Zhang (2 shared papers)Jie Deng (1 shared paper)
- Journals
- Frontiers in Oncology (11 papers)PLoS ONE (11 papers)BMC Cancer (10 papers)Frontiers in Genetics (10 papers)Journal of Clinical Oncology (9 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Wang
501 papers receiving 11.6k citations
Wei Wang's Hit Papers
Peers
Comparison fields: 5 of 163
- Cancer Research 3.9k
- Molecular Biology 5.9k
- Immunology 1.2k
- Oncology 1.4k
- Reproductive Medicine 366
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 526 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 472 | |
| 2 | Human body epigenome maps reveal noncanonical DNA methylation variation Hit paper breakdown → | 2015 | 428 |
| 3 | Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury Hit paper breakdown → | 2021 | 400 |
| 4 | 2010 | 276 | |
| 5 | Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets Hit paper breakdown → | 2023 | 225 |
| 6 | 2019 | 217 | |
| 7 | 2015 | 164 | |
| 8 | 2016 | 136 | |
| 9 | 2015 | 132 | |
| 10 | 2013 | 124 | |
| 11 | 1995 | 119 | |
| 12 | 2013 | 119 | |
| 13 | 2018 | 109 | |
| 14 | 2012 | 108 | |
| 15 | 2019 | 106 | |
| 16 | 2019 | 104 | |
| 17 | 2017 | 103 | |
| 18 | 2021 | 102 | |
| 19 | 2018 | 98 | |
| 20 | 2006 | 96 |
About Wei Wang
Wei Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 526 papers that have together received 11.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (106 papers), MicroRNA in disease regulation (61 papers), RNA modifications and cancer (60 papers), Circular RNAs in diseases (49 papers), Epigenetics and DNA Methylation (38 papers), RNA Research and Splicing (28 papers), Cancer-related gene regulation (24 papers) and Lung Cancer Treatments and Mutations (22 papers). The work is most often cited by research in Cancer Research (3.9k citations), Molecular Biology (5.9k citations), Immunology (1.2k citations), Oncology (1.4k citations) and Reproductive Medicine (366 citations). Wei Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jianxin Qiu, Zuowei Li, Yigang Zeng, Ming Luo, Zhihong Liu, Robert Shoemaker, Kun Zhang, Jie Deng, Yunping Luo and John W. Whitaker. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, BMC Cancer, Frontiers in Genetics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.